Тёмный

Research Spotlight Webinar: Using CRISPR for HD Drug Development, Ricardo Mouro Pinto, 2/22/24 

Подписаться
Просмотров 278
% 5

Watch the Hereditary Disease Foundation Research Spotlight Webinar "Using CRISPR for HD Drug Development," by Ricardo Mouro Pinto, PhD, Harvard Medical School, Massachusetts General Hospital, followed by Ask the Scientist.
The Hereditary Disease Foundation Research Spotlight Webinar series features brilliant scientists working to identify treatments and cures for Huntington's disease and other brain disorders.
About the Speaker
Ricardo Mouro Pinto, PhD
Instructor in Neurology, Harvard Medical School
Massachusetts General Hospital
2023 HDF Transformative Research Award Recipient
Dr. Mouro Pinto is interested in human genetics and neurosciences, with a strong research focus on repeat expansion-associated disorders, such as Huntington’s disease and Friedreich's Ataxia, particularly concerning mechanisms of trinucleotide repeat instability.
Dr. Mouro Pinto received HDF’s 2023 Transformative Research Award for his project developing genome editing therapeutics that target the cause of the CAG repeat expansion in Huntington’s disease. If successful, this work will lead to pre-clinical studies testing the effect of altering MLH3, MSH3, and PMS1 on behavior of mice that model HD.

Опубликовано:

 

26 фев 2024

Поделиться:

Ссылка:

Скачать:

Готовим ссылку...

Добавить в:

Мой плейлист
Посмотреть позже
Комментарии